The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the upcoming respiratory virus season, but without input from its independent vaccine ...
In a year that saw advisory committees placed under a particularly bright microscope at the FDA, the agency held fewer ...
The Food and Drug Administration on Wednesday canceled a planned March 13 committee meeting to update next winter's flu shot. Why it matters: It's the second vaccine policy meeting to be canceled ...
The researchers found that 48% of speakers are patients and family members, 99% of whom support drug approval. HealthDay News — Most speakers attending US Food and Drug Administration (FDA) Human Drug ...
The Food and Drug Administration unexpectedly canceled an annual meeting of its advisers to update next season's influenza vaccines, raising concerns about the timeline for manufacturing next winter's ...
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from ...
Biohaven said the U.S. Food and Drug Administration no longer plans to hold an advisory-committee meeting on the biopharmaceutical company's proposed troriluzole treatment for the rare genetic disease ...
Overall, 82%, 11%, and 7% of speakers supported drug approval, opposed approval, and were neutral, respectively. (HealthDay News) — Most speakers attending US Food and Drug Administration (FDA) Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback